EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Between enhancement and risk: A critical review of psychedelic microdosing

Iva Totomanova, Eline C H M Haijen, Petra P M Hurks, Johannes G Ramaekers, Kim P C Kuypers

Current Opinion in Psychology · 2025

DOI: 10.1016/j.copsyc.2025.102129 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Current Opinion in Psychology, 2025. Verfasst von Iva Totomanova und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neuropsychology and Psychopharmacology, Faculty of Psychology and Neuroscience, Maastricht University, Maastricht, the Netherlands. Hauptthemen laut MEDLINE: Hallucinogens, Psilocybin, Lysergic Acid Diethylamide. Die Arbeit nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Microdosing psychedelics, the regular use of low doses of LSD or psilocybin, have attracted growing public and scientific interest. This review synthesizes findings from 57 human studies on psychological and physiological outcomes in clinical and non-clinical populations. Reported benefits include improved mood, enhanced cognition, social functioning, and mental health, although findings are inconsistent and largely self-reported. Adverse effects such as anxiety, physical discomfort, and cognitive disruption are also frequently reported. Outcomes appear to be highly individual and shaped by user expectations, context, and baseline state. Notably, many experimental studies focus on the acute effects of single low doses, whereas observational studies reflect repeated use and generally report more benefits, while experimental trials tend to yield more null findings. Differences between observational and experimental findings highlight the need for rigorous, placebo-controlled research. While microdosing shows potential in some studies, current evidence remains inconclusive and warrants caution.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HallucinogensPsilocybinLysergic Acid DiethylamideHumansCognitionAffectDose-Response Relationship, Drug

Substanzen

HallucinogensPsilocybinLysergic Acid Diethylamide

Autor:innen und Institutionen

  • Department of Neuropsychology and Psychopharmacology, Faculty of Psychology and Neuroscience, Maastricht University, Maastricht, the Netherlands.
  • Department of Neuropsychology and Psychopharmacology, Faculty of Psychology and Neuroscience, Maastricht University, Maastricht, the Netherlands. Electronic address: k.kuypers@maastrichtuniversity.nl.

Zitieren

APA

Totomanova, I., Haijen, E. C. H. M., Hurks, P. P. M., Ramaekers, J. G., & Kuypers, K. P. C. (2025). Between enhancement and risk: A critical review of psychedelic microdosing. Current Opinion in Psychology. https://doi.org/10.1016/j.copsyc.2025.102129

Vancouver

Totomanova I, Haijen ECHM, Hurks PPM, Ramaekers JG, Kuypers KPC. Between enhancement and risk: A critical review of psychedelic microdosing. Current Opinion in Psychology. 2025. doi:10.1016/j.copsyc.2025.102129

BibTeX
@article{Totomanova2025,
  author = {Totomanova, Iva and Haijen, Eline C H M and Hurks, Petra P M and Ramaekers, Johannes G and Kuypers, Kim P C},
  title = {Between enhancement and risk: A critical review of psychedelic microdosing},
  journal = {Current Opinion in Psychology},
  year = {2025},
  doi = {10.1016/j.copsyc.2025.102129}
}
Kostenlos starten →